Logotype for IPG Photonics Corporation

IPG Photonics (IPGP) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for IPG Photonics Corporation

Q4 2024 earnings summary

17 Dec, 2025

Executive summary

  • Q4 2024 revenue reached $234.3 million, at the high end of guidance, but down 22% year-over-year due to weak industrial, automotive, and medical demand, with growth in advanced and emerging applications.

  • Gross margin improved to 38.6%, up 40 basis points year-over-year, aided by cost reductions and lower product, shipping, and tariff costs, despite lower manufacturing absorption.

  • Net income for Q4 was $7.8 million, with EPS of $0.18, both down sharply from prior year due to unusual tax items and lower sales.

  • Free cash flow and operating cash flow remained strong, with $930 million in cash and no debt, providing flexibility for strategic investments.

  • Strategic focus is on cost reduction, product innovation, and targeted investments in high-growth areas such as urology, micromachining, and advanced applications.

Financial highlights

  • Q4 revenue was $234.3 million, down 22% year-over-year, up 1% sequentially, with foreign currency reducing revenue by 1%.

  • Gross margin was 38.6%, up from 38.2% year-over-year.

  • GAAP operating income was $14 million; operating margin 6.0% (down from 9.6% YoY); net income $7.8 million; EPS $0.18 (down 80% YoY).

  • Effective tax rate was 64% due to unusual tax items, including repatriation of cash, reducing EPS by $0.08.

  • Cash from operations was $74 million; capital expenditures were $23 million in Q4 and $98.5 million for the year; $57 million spent on share repurchases in Q4, $344 million for the year.

Outlook and guidance

  • Q1 2025 revenue expected between $210 million and $240 million; gross margin guidance is 36%-39%.

  • Operating expenses projected at $82-$84 million in Q1, increasing further in Q2 and remaining elevated through 2025.

  • Adjusted EPS for Q1 expected in the range of $0.05-$0.35; adjusted EBITDA between $19 million-$35 million.

  • 2025 CapEx expected at $105-$115 million, mainly for manufacturing capacity in Germany.

  • Free cash flow expected to improve significantly in 2026 after current investment cycle.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more